Last reviewed · How we verify

NCT04002856

Aesthetic Performance of "Profhilo®" Injective Intradermal Treatment for the Neck

Completed NA Last updated 18 July 2019
What this trial tests

NA trial testing Profhilo® in Skin Manifestations in 25 participants. Completed in 21 June 2019.

Timeline
18 February 2019
Primary endpoint
21 June 2019
21 June 2019

Quick facts

Lead sponsorDerming SRL
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment25
Start date18 February 2019
Primary completion21 June 2019
Estimated completion21 June 2019
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Derming SRL — full company profile →

Who can join

Adults 40 to 65, female only, with Skin Manifestations. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to investigate the aesthetic performance of the Hyaluronic acid (HA)-based dermal filler Profhilo® injected by a novel bio aesthetic point technique ("BAP" techinique ) in woman aged 40-65 years with skin flaccidity and roughness of the neck.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy and Tolerability of Hybrid Complexes of High- and Low-Molecular-Weight Hyaluronan Intradermal Injections for the Treatment of Skin Roughness and Laxity of the Neck.
    Sparavigna A, Bombelli L, Giori AM, Bellia G. · · 2022 · cited 12× · PMID 36164489 · DOI 10.1155/2022/4497176

Verify or expand the search:

Other trials of Profhilo®

Trials testing the same drug.

Other recruiting trials for Skin Manifestations

Currently open trials in the same condition.

Other Derming SRL trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04002856.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing